Extended drug trial seeks to tame debilitating muscle disease

NCT ID NCT04264442

Summary

This study aimed to check the long-term safety of a drug called losmapimod for adults with facioscapulohumeral muscular dystrophy (FSHD), a condition that weakens muscles. It was an extension of a previous trial, allowing participants to continue taking the drug. The main goal was to monitor for any side effects or health changes over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU de NICE- CHU pasteur2

    Nice, 06001, France

  • Hospital UiP La Fe

    Valencia, 46026, Spain

  • Hospital de la Sta Creu i St Pau

    Barcelona, 08041, Spain

  • Kennedy Krieger Institute

    Baltimore, Maryland, 21205, United States

  • Montreal Neurological Institute and Hospital

    Montreal, Quebec, H3A 2B4, Canada

  • Ohio State University

    Columbus, Ohio, 43221, United States

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, K1Y 4E9, Canada

  • University of California Irvine

    Irvine, California, 92868, United States

  • University of California Los Angeles (UCLA)

    Los Angeles, California, 90095, United States

  • University of Florida

    Gainesville, Florida, 32610, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts, 01655, United States

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

  • University of Washinton Medical Center

    Seattle, Washington, 98195, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.